XBI-SPY overlay unravels great bear?Undead Bear Captain's Log, Apr 7 2025:
Writing some observations due to a lurking feeling of something ominous about to happen:
Bizarre signs in the wind since mid-March, such as VVIX/VIX
Sudden downslide last week, almost unprecedented
Minimal put action - bear breathen all obliterated
Overlay
Key stats
About SPDR Series Trust SPDR S&P Biotech ETF
Home page
Inception date
Jan 31, 2006
Structure
Open-Ended Fund
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
SSgA Funds Management, Inc.
Distributor
State Street Corp. (Fund Distributor)
XBI provides exposure to US biotech stocks, as defined by GICS, from a universe that invests across the market-cap spectrum. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market-cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap. The index is rebalanced quarterly.
Classification
What's in the fund
Exposure type
Health Technology
Stock breakdown by region
Top 10 holdings
Opening (IRA): XBI May 16th -91C/October 17th 60C LCD*... for a 26.56 debit.
Comments: Back in to XBI on weakness, buying the back month 90 delta and selling the front month that pays for all of the extrinsic in the long. (The back month 60C is shown at the 80 so that it fits on the chart).
Metrics:
Buying Power Effect: 26.56
Break Even: 86.56
Max
Opening (IRA): XBI May 16th -85C/December 19th 50C LCD*... for a 29.50 debit.
Comments: Adding to my XBI position at or near 52-week lows, buying the back month 90 delta and selling the front month -30 delta that pays for all of the extrinsic in the long. (The 50C is depicted at a higher strike so that it fits on the chart).
Metrics:
Buying Power E
Opening (IRA): XBI Sept 19th 60C/April 17th -90C LCD*... for a 26.68 debit.
Comments: Taking a bullish assumption directional shot near 52 week lows, buying the 90 delta back month and selling a front month that pays for all the extrinsic in the long, resulting in a break even that is at or below where the underlying is currently trading. The 60 lo
Opening (IRA): XBI March 21st 85 Covered Call... for an 83.52 debit.
Comments: One of the only red things on my ETF board ... . Selling the -75 delta call against shares to emulate the delta metrics of a 25 delta short put, but with the built-in defense of the short call. Just trying to squeeze in a little more into March while the monthly
$XBI Starting New Bullish Trend?AMEX:XBI has been range bound (wide range) for a year. Recently it has been in a downtrend as defined by lower highs and lower lows. However, it looks like we now have a recent higher high and (maybe) a higher low. There are still technical challenges like it is under all moving averages. It would
Opening (IRA): XBI March 21st 86 Covered Call... for an 84.20 debit.
Comments: Adding to my position at strikes better than what I currently have on, selling the -75 delta call against shares to emulate the delta metrics of a 25 delta short put, but with the built-in defense of the short call.
Metrics:
Buying Power Effect/Break Even: 84.20
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.